Reffo G C, Pitzorno G, Perin S, Forattini C
Minerva Med. 1980 Jan 14;71(1):49-54.
The results of a study carried out with pindolol (Visken-Sandoz, 5 mg tablets) are reported. The study had the following objectives: 1) to assess the hypotensive effect of the drug in a group of 45 outpatients; 2) to establish effectiveness variations on the basis of the number of daily administrations and doses; 3) to monitor the behaviour of arterial pressure under effort before and after the period of the study. The results obtained show that, for hypertensive patients classifiable in WHO groups 1 and 2, pindolol is effective and recommended unconditionally for out-patient treatment. In most of the patients, two administrations a day are sufficient to maintain pressure values within acceptable limits.
报告了一项使用吲哚洛尔(心得静-山德士,5毫克片剂)进行的研究结果。该研究有以下目标:1)评估该药物在45名门诊患者中的降压效果;2)根据每日给药次数和剂量确定疗效差异;3)在研究期间前后监测运动时的动脉压变化情况。所得结果表明,对于世界卫生组织分类为1级和2级的高血压患者,吲哚洛尔是有效的,并且无条件推荐用于门诊治疗。在大多数患者中,每天两次给药足以将血压值维持在可接受范围内。